Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 180

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Review article: the investigation and management of gastric neuroendocrine tumours

Basuroy, R., Srirajaskanthan, R., Prachalias, A., Quaglia, A., Ramage, J. K. · 2014 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Gastric carcinoids (GC s) or neuroendocrine tumours (NET s) are increasingly identified at endoscopy, and account for 0.6–2% of all gastric polyps identified. The SEER database in the US has demonstrated a rising incidence of gastric NET s amongst all NET s; from 2.2% between 1950 and 1969 to 6.0% between 2000 and 2007. Aim: To review the literature and assist clinicians in managing patients with GC s. Methods: A literature search was conducted through MEDLINE using search terms: gastric, carcinoid, neuroendocrine tumour, therapy, endoscopy, mucosal resection, submucosal dissection. Relevant articles were identified through manual review. The reference lists of these articles were reviewed to include further appropriate articles. Results: There are three types of GC s with important epidemiological, pathophysiological, histological and endoscopic differences that affect prognosis and management. Type 1 and 2 GC s develop in the context of hypergastrinaemia that originates from achlorhydria in atrophic gastritis and a gastrinoma, respectively. Type 3 GC s occur sporadically and independent of gastrin. The histological type, grade and Ki67 index are used to determine prognosis and direct clinical management. Type 1 GC s >1 cm in size and type 2 GC s should be assessed for invasion beyond the submucosa with EUS prior to endoscopic resection with EMR or ESD. Type 3 GC s should be managed as per recommendations for gastric adenocarcinoma. The treatment of advanced disease is multimodal. Conclusions: Patients with gastric carcinoids should be discussed in a specialist neuroendocrine tumour multidisciplinary meeting to ensure all treatment options are explored in localised and advanced disease. Areas of controversy exist that need further research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.12698

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

  • The role of endoscopy in the management of premalignant and malignant conditions of the stomach

    Evans, J. A., Chandrasekhara, V., Chathadi, K. V., Decker, G. A., Early, D. S., Fisher, D. A., Foley, K., Hwang, J. H., Jue, T. L., Lightdale, J. R., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1967 · Cited by 304

    “Five- and 10-year survival of patients with type 1 gastric carcinoid is no different from that of the general population,(70) and clinical management is not well defined because both endoscopic surveillance alone and polypectomy with surveillance have been advocated.(68,69,71) Type 2 gastric carcinoids affect men and…”
    Background

See all 180

Metadata

Authors
Basuroy, R., Srirajaskanthan, R., Prachalias, A., Quaglia, A., & Ramage, J. K.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2014-03-13
Volume
39
Issue
10
Pages
1071-1084
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2169555547
Cited by
180
References
6
FWCI
11.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review article: the investigation and management of gastric neuroendocrine tumours. https://app.cochat.ai/papers/10.1111/apt.12698
The paper
Basuroy, R., Srirajaskanthan, R., Prachalias, A., Quaglia, A., & Ramage, J. K. (2014). Review article: the investigation and management of gastric neuroendocrine tumours. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.12698

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.